Literature DB >> 9208124

Cryptosporidiosis after CD34-selected autologous peripheral blood stem cell transplantation (PBSCT). Treatment with paromomycin, azithromycin and recombinant human interleukin-2.

D Nachbaur1, G Kropshofer, H Feichtinger, F Allerberger, D Niederwieser.   

Abstract

We report two cases of cryptosporidiosis after CD34-selected PBSCT for lymphoma. While the first patient died of pulmonary cryptosporidiosis, treatment with paromomycin, azithromycin and subcutaneous low-dose rhIL-2 to improve numerical and functional T lymphocyte defects completely eliminated infection in the second patient. We conclude, that the removal of mature T lymphocytes by positive selection of CD34+ cells bears the risk of a delayed immune reconstitution resulting in an increased incidence of severe and sometimes fatal opportunistic infections. IL-2 might be useful in this situation by accelerating immune reconstitution and reducing the danger of opportunistic infections.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9208124     DOI: 10.1038/sj.bmt.1700826

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  5 in total

Review 1.  Epidemiology and clinical features of Cryptosporidium infection in immunocompromised patients.

Authors:  Paul R Hunter; Gordon Nichols
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

2.  Adipose tissue-derived mesenchymal stem cells as a new host cell in latent leishmaniasis.

Authors:  Adil M Allahverdiyev; Melahat Bagirova; Serhat Elcicek; Rabia Cakir Koc; Serap Yesilkir Baydar; Necati Findikli; Olga N Oztel
Journal:  Am J Trop Med Hyg       Date:  2011-09       Impact factor: 2.345

3.  Hemopoietic recovery and infectious complications in breast cancer and multiple myeloma after autologous CD34+ cell-selected peripheral blood progenitor cell transplantation.

Authors:  Luca De Rosa; Gabriel Anghel; Annino Pandolfi; Massimo Riccardi; Rachele Amodeo; Ignazio Majolino
Journal:  Int J Hematol       Date:  2004-01       Impact factor: 2.490

4.  Prevalence of Cryptosporidium, Blastocystis, and other opportunistic infections in patients with primary and acquired immunodeficiency.

Authors:  Małgorzata Bednarska; Irena Jankowska; Andrzej Pawelas; Karolina Piwczyńska; Anna Bajer; Beata Wolska-Kuśnierz; Małgorzata Wielopolska; Renata Welc-Falęciak
Journal:  Parasitol Res       Date:  2018-06-26       Impact factor: 2.289

Review 5.  Cryptosporidium infection in solid organ transplantation.

Authors:  Diana F Florescu; Uriel Sandkovsky
Journal:  World J Transplant       Date:  2016-09-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.